Chronic gastritis: from histological protocol to substantiation of etiopathogenetic therapy
Gastritis is a reaction of the mucous membrane (MM) of the stomach to damage and is characterized by the formation of inflammatory, dystrophic and dysregenerative changes in the MM of the stomach, as well as atrophy of epithelial cells with replacement of normal glands with fibrous tissue. The progr...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Open Systems Publication
2021-06-01
|
| Series: | Лечащий Врач |
| Subjects: | |
| Online Access: | https://journal.lvrach.ru/jour/article/view/11 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850065222521323520 |
|---|---|
| author | I. V. Dolgalev E. N. Kareva E. A. Lyalyukova N. V. Pavlova |
| author_facet | I. V. Dolgalev E. N. Kareva E. A. Lyalyukova N. V. Pavlova |
| author_sort | I. V. Dolgalev |
| collection | DOAJ |
| description | Gastritis is a reaction of the mucous membrane (MM) of the stomach to damage and is characterized by the formation of inflammatory, dystrophic and dysregenerative changes in the MM of the stomach, as well as atrophy of epithelial cells with replacement of normal glands with fibrous tissue. The progression of chronic gastritis (CG) is accompanied by the development of MM atrophy, dysplasia and becomes a significant factor in the formation of gastric malignant neoplasms. The article presents the modern etiological classification of CG, approaches to the diagnosis of CG, assessing the stage of gastritis on a scale of progressive increase in the likelihood of developing stomach cancer, presents the histological characteristics, and also substantiates etiopathogenetic approaches to the treatment of various forms of CG, including methods for optimizing the eradication therapy of H. pylori infection. which can be used to increase the effectiveness of not only standard triple therapy, but also other anti-Helicobacter treatment regimens. The use of proton pump inhibitors in the treatment of gastritis is considered. |
| format | Article |
| id | doaj-art-53dcbc2c83be45e1af301fa9960875a1 |
| institution | DOAJ |
| issn | 1560-5175 2687-1181 |
| language | Russian |
| publishDate | 2021-06-01 |
| publisher | Open Systems Publication |
| record_format | Article |
| series | Лечащий Врач |
| spelling | doaj-art-53dcbc2c83be45e1af301fa9960875a12025-08-20T02:49:05ZrusOpen Systems PublicationЛечащий Врач1560-51752687-11812021-06-0102303410.26295/OS.2021.76.84.00610Chronic gastritis: from histological protocol to substantiation of etiopathogenetic therapyI. V. Dolgalev0E. N. Kareva1E. A. Lyalyukova2N. V. Pavlova3FSBEI HE Siberian State Medical University of the Ministry of Health of RussiaN. I. Pirogov Russian National Research Medical University of the Ministry of Helth of Russia; I. M. Sechenov first Moscow state medical universityFFSBEI HE Omsk State Medical University of the Ministry of Health of RussiaFSBEI HE Moscow State University of Medicine and Dentistry n. a. A. I. Evdokimov of the Ministry of Health of RussiaGastritis is a reaction of the mucous membrane (MM) of the stomach to damage and is characterized by the formation of inflammatory, dystrophic and dysregenerative changes in the MM of the stomach, as well as atrophy of epithelial cells with replacement of normal glands with fibrous tissue. The progression of chronic gastritis (CG) is accompanied by the development of MM atrophy, dysplasia and becomes a significant factor in the formation of gastric malignant neoplasms. The article presents the modern etiological classification of CG, approaches to the diagnosis of CG, assessing the stage of gastritis on a scale of progressive increase in the likelihood of developing stomach cancer, presents the histological characteristics, and also substantiates etiopathogenetic approaches to the treatment of various forms of CG, including methods for optimizing the eradication therapy of H. pylori infection. which can be used to increase the effectiveness of not only standard triple therapy, but also other anti-Helicobacter treatment regimens. The use of proton pump inhibitors in the treatment of gastritis is considered.https://journal.lvrach.ru/jour/article/view/11gastritischronic gastritish. pylorihelicobacter pyloriproton pump inhibitors |
| spellingShingle | I. V. Dolgalev E. N. Kareva E. A. Lyalyukova N. V. Pavlova Chronic gastritis: from histological protocol to substantiation of etiopathogenetic therapy Лечащий Врач gastritis chronic gastritis h. pylori helicobacter pylori proton pump inhibitors |
| title | Chronic gastritis: from histological protocol to substantiation of etiopathogenetic therapy |
| title_full | Chronic gastritis: from histological protocol to substantiation of etiopathogenetic therapy |
| title_fullStr | Chronic gastritis: from histological protocol to substantiation of etiopathogenetic therapy |
| title_full_unstemmed | Chronic gastritis: from histological protocol to substantiation of etiopathogenetic therapy |
| title_short | Chronic gastritis: from histological protocol to substantiation of etiopathogenetic therapy |
| title_sort | chronic gastritis from histological protocol to substantiation of etiopathogenetic therapy |
| topic | gastritis chronic gastritis h. pylori helicobacter pylori proton pump inhibitors |
| url | https://journal.lvrach.ru/jour/article/view/11 |
| work_keys_str_mv | AT ivdolgalev chronicgastritisfromhistologicalprotocoltosubstantiationofetiopathogenetictherapy AT enkareva chronicgastritisfromhistologicalprotocoltosubstantiationofetiopathogenetictherapy AT ealyalyukova chronicgastritisfromhistologicalprotocoltosubstantiationofetiopathogenetictherapy AT nvpavlova chronicgastritisfromhistologicalprotocoltosubstantiationofetiopathogenetictherapy |